Literature DB >> 20676058

Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.

Nicolas Reynoird1, Brian E Schwartz, Manuela Delvecchio, Karin Sadoul, David Meyers, Chandrani Mukherjee, Cécile Caron, Hiroshi Kimura, Sophie Rousseaux, Philip A Cole, Daniel Panne, Christopher A French, Saadi Khochbin.   

Abstract

In a subset of poorly differentiated and highly aggressive carcinoma, a chromosomal translocation, t(15;19)(q13;p13), results in an in-frame fusion of the double bromodomain protein, BRD4, with a testis-specific protein of unknown function, NUT (nuclear protein in testis). In this study, we show that, after binding to acetylated chromatin through BRD4 bromodomains, the NUT moiety of the fusion protein strongly interacts with and recruits p300, stimulates its catalytic activity, initiating cycles of BRD4-NUT/p300 recruitment and creating transcriptionally inactive hyperacetylated chromatin domains. Using a patient-derived cell line, we show that p300 sequestration into the BRD4-NUT foci is the principal oncogenic mechanism leading to p53 inactivation. Knockdown of BRD4-NUT released p300 and restored p53-dependent regulatory mechanisms leading to cell differentiation and apoptosis. This study demonstrates how the off-context activity of a testis-specific factor could markedly alter vital cellular functions and significantly contribute to malignant cell transformation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676058      PMCID: PMC2944051          DOI: 10.1038/emboj.2010.176

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

Authors:  Erin M Bowers; Gai Yan; Chandrani Mukherjee; Andrew Orry; Ling Wang; Marc A Holbert; Nicholas T Crump; Catherine A Hazzalin; Glen Liszczak; Hua Yuan; Cecilia Larocca; S Adrian Saldanha; Ruben Abagyan; Yan Sun; David J Meyers; Ronen Marmorstein; Louis C Mahadevan; Rhoda M Alani; Philip A Cole
Journal:  Chem Biol       Date:  2010-05-28

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

3.  Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.

Authors:  J Govin; C Lestrat; C Caron; C Pivot-Pajot; S Rousseaux; S Khochbin
Journal:  Ernst Schering Res Found Workshop       Date:  2006

Review 4.  Epigenetic reprogramming of the male genome during gametogenesis and in the zygote.

Authors:  S Rousseaux; N Reynoird; E Escoffier; J Thevenon; C Caron; S Khochbin
Journal:  Reprod Biomed Online       Date:  2008-04       Impact factor: 3.828

5.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

6.  New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators.

Authors:  Sophie Rousseaux; Saadi Khochbin
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

7.  Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4.

Authors:  Cheng-Ming Chiang
Journal:  F1000 Biol Rep       Date:  2009-12-15

8.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

Authors:  Christopher A French; Isao Miyoshi; Ichiro Kubonishi; Holcombe E Grier; Antonio R Perez-Atayde; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

9.  Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability.

Authors:  A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2008-11-26       Impact factor: 5.157

10.  BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Authors:  C A French; C L Ramirez; J Kolmakova; T T Hickman; M J Cameron; M E Thyne; J L Kutok; J A Toretsky; A K Tadavarthy; U R Kees; J A Fletcher; J C Aster
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

View more
  81 in total

1.  Drug discovery: Reader's block.

Authors:  Sean D Taverna; Philip A Cole
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

2.  Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.

Authors:  Ranran Wang; Xing-Jun Cao; Katarzyna Kulej; Wei Liu; Tongcui Ma; Margo MacDonald; Cheng-Ming Chiang; Benjamin A Garcia; Jianxin You
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

3.  BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.

Authors:  Miguel F Segura; Bárbara Fontanals-Cirera; Avital Gaziel-Sovran; María V Guijarro; Doug Hanniford; Guangtao Zhang; Pilar González-Gomez; Marta Morante; Luz Jubierre; Weijia Zhang; Farbod Darvishian; Michael Ohlmeyer; Iman Osman; Ming-Ming Zhou; Eva Hernando
Journal:  Cancer Res       Date:  2013-08-15       Impact factor: 12.701

4.  CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.

Authors:  Inga-Marie Schaefer; Paola Dal Cin; Latrice M Landry; Christopher D M Fletcher; Glenn J Hanna; Christopher A French
Journal:  Genes Chromosomes Cancer       Date:  2018-08-14       Impact factor: 5.006

5.  Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.

Authors:  Y Huang; A Chuang; H Hao; C Talbot; T Sen; B Trink; D Sidransky; E Ratovitski
Journal:  Cell Death Differ       Date:  2011-01-28       Impact factor: 15.828

Review 6.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 7.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

8.  NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.

Authors:  Femke M Hormann; Alex Q Hoogkamer; H Berna Beverloo; Aurélie Boeree; Ilse Dingjan; Moniek M Wattel; Ronald W Stam; Gabriele Escherich; Rob Pieters; Monique L den Boer; Judith M Boer
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

9.  Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.

Authors:  Artyom A Alekseyenko; Erica M Walsh; Barry M Zee; Tibor Pakozdi; Peter Hsi; Madeleine E Lemieux; Paola Dal Cin; Tan A Ince; Peter V Kharchenko; Mitzi I Kuroda; Christopher A French
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

10.  Chromatin Hyperacetylation Impacts Chromosome Folding by Forming a Nuclear Subcompartment.

Authors:  Celeste D Rosencrance; Haneen N Ammouri; Qi Yu; Tiffany Ge; Emily J Rendleman; Stacy A Marshall; Kyle P Eagen
Journal:  Mol Cell       Date:  2020-04-02       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.